Molecular mechanisms of the anti-cancer drug, LY2874455, in overcoming the FGFR4 mutation-based resistance

[1]  A. Iwama,et al.  The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma , 2021, Scientific Reports.

[2]  Yongheng Chen,et al.  FGFR-TKI resistance in cancer: current status and perspectives , 2021, Journal of Hematology & Oncology.

[3]  S. Oesterreich,et al.  FGFR4: A promising therapeutic target for breast cancer and other solid tumors. , 2020, Pharmacology & therapeutics.

[4]  M. Wing,et al.  Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma , 2020, Molecular Cancer Therapeutics.

[5]  A. Shibata,et al.  FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy , 2019, International journal of molecular sciences.

[6]  Adrian V. Lee,et al.  FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype , 2019, npj Breast Cancer.

[7]  Sung‐Min Ahn,et al.  FGF19–FGFR4 Signaling in Hepatocellular Carcinoma , 2019, Cells.

[8]  S. Danopoulos,et al.  FGF Signaling in Lung Development and Disease: Human Versus Mouse , 2019, Front. Genet..

[9]  O. Myklebost,et al.  Preclinical Evaluation of the Pan-FGFR Inhibitor LY2874455 in FRS2-Amplified Liposarcoma , 2019, Cells.

[10]  Yong Teng,et al.  Fibroblast Growth Factor Receptor 4 Targeting in Cancer: New Insights into Mechanisms and Therapeutic Strategies † , 2019, Cells.

[11]  Yongheng Chen,et al.  LY2874455 potently inhibits FGFR gatekeeper mutants and overcomes mutation-based resistance. , 2018, Chemical communications.

[12]  Qianming Chen,et al.  Role of fibroblast growth factor receptor 4 in cancer , 2018, Cancer science.

[13]  Ron O. Dror,et al.  Molecular Dynamics Simulation for All , 2018, Neuron.

[14]  Y. Bang,et al.  A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer , 2017, Targeted Oncology.

[15]  G. Frühbeck,et al.  The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes , 2017, Current Diabetes Reports.

[16]  N. Turner,et al.  Advances and challenges in targeting FGFR signalling in cancer , 2017, Nature Reviews Cancer.

[17]  H. Ohta,et al.  Roles of FGF Signals in Heart Development, Health, and Disease , 2016, Front. Cell Dev. Biol..

[18]  Yongheng Chen,et al.  Crystal Structure of the FGFR4/LY2874455 Complex Reveals Insights into the Pan-FGFR Selectivity of LY2874455 , 2016, PloS one.

[19]  M. Katoh.  FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review) , 2016, International journal of molecular medicine.

[20]  Philippe Soriano,et al.  Genetic insights into the mechanisms of Fgf signaling , 2016, Genes & development.

[21]  R. Huber,et al.  Structural analysis of the human fibroblast growth factor receptor 4 kinase. , 2014, Journal of molecular biology.

[22]  N. Gray,et al.  DFG-out Mode of Inhibition by an Irreversible Type-1 Inhibitor Capable of Overcoming Gate-Keeper Mutations in FGF Receptors , 2014, ACS chemical biology.

[23]  Youyong Li,et al.  Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. , 2014, Physical chemistry chemical physics : PCCP.

[24]  Duncan Poole,et al.  Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald. , 2013, Journal of chemical theory and computation.

[25]  Daniel R Roe,et al.  PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. , 2013, Journal of chemical theory and computation.

[26]  Andreas W. Götz,et al.  SPFP: Speed without compromise - A mixed precision model for GPU accelerated molecular dynamics simulations , 2013, Comput. Phys. Commun..

[27]  L. Staudt,et al.  Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. , 2009, The Journal of clinical investigation.

[28]  M. Korc,et al.  The role of fibroblast growth factors in tumor growth. , 2009, Current cancer drug targets.

[29]  Leo S. D. Caves,et al.  Bio3d: An R Package , 2022 .

[30]  Holger Gohlke,et al.  The Amber biomolecular simulation programs , 2005, J. Comput. Chem..

[31]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[32]  Josep Ramón Goñi,et al.  Molecular dynamics simulations: advances and applications , 2015, Advances and applications in bioinformatics and chemistry : AABC.

[33]  H. Prado,et al.  Advances and Applications , 2010 .

[34]  David A. Case,et al.  On finding stationary states on large-molecule potential energy surfaces , 1985 .